Business Description
BioRegenx Inc
NAICS : 923120
SIC : 7372
ISIN : US31772N1000
Total Employee Number:
6Description
BioRegenx Inc develops and manufactures medical test equipment and high-quality, science-based nutritional products. The Company distributes wellness devices. The products are sold nationally through a direct selling channel to health professionals and research organizations. The company operates and manages its business as one reportable and operating segment as a medical testing, diagnostic and nutraceutical company. It focuses on commercialization of its patented technologies in its field.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -13.45 | |||||
Debt-to-Equity | -0.48 | |||||
Debt-to-EBITDA | -2.34 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -171.48 | |||||
Beneish M-Score | -21.88 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Book Growth Rate | -71 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.43 | |||||
9-Day RSI | 40.98 | |||||
14-Day RSI | 42.17 | |||||
3-1 Month Momentum % | -20.19 | |||||
6-1 Month Momentum % | -17 | |||||
12-1 Month Momentum % | -38.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.05 | |||||
Quick Ratio | 0.02 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 132.58 | |||||
Days Sales Outstanding | 6.32 | |||||
Days Payable | 644.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -53.2 | |||||
Shareholder Yield % | -0.79 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 81.82 | |||||
Operating Margin % | -21.23 | |||||
Net Margin % | -73.78 | |||||
EBITDA Margin % | -52.38 | |||||
FCF Margin % | 1.59 | |||||
OCF Margin % | 1.59 | |||||
ROA % | -183.52 | |||||
ROIC % | -14.63 | |||||
3-Year ROIIC % | -20.52 | |||||
ROC (Joel Greenblatt) % | -594.53 | |||||
Moat Score | 1 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
PS Ratio | 7.6 | |||||
EV-to-EBIT | -9.5 | |||||
EV-to-EBITDA | -10.27 | |||||
EV-to-Revenue | 5.38 | |||||
EV-to-FCF | 339.43 | |||||
Price-to-GF-Value | 0.76 | |||||
Earnings Yield (Greenblatt) % | -10.53 | |||||
FCF Yield % | 0.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BRGX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioRegenx Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.766 | ||
| EPS (TTM) ($) | - | ||
| Beta | -0.8924 | ||
| 3-Year Sharpe Ratio | 0.07 | ||
| 3-Year Sortino Ratio | 0.12 | ||
| Volatility % | 82.41 | ||
| 14-Day RSI | 42.17 | ||
| 14-Day ATR ($) | 0.000172 | ||
| 20-Day SMA ($) | 0.007785 | ||
| 12-1 Month Momentum % | -38.52 | ||
| 52-Week Range ($) | 0.0075 - 0.03 | ||
| Shares Outstanding (Mil) | 971.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioRegenx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioRegenx Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.033333:1 Stock Split | 2011-03-25 | 2.40 (-20.00%) | ||
| 0.01:1 Stock Split | 2010-07-08 | 0.06 (-66.67%) | ||
| 3:1 Stock Split | 2004-05-13 | 111.00 (+0.00%) | ||
| 0.0667:1 Stock Split | 2004-02-27 | 1,049.49 (-36.36%) | ||
| 0.2:1 Stock Split | 2002-10-23 | 6,754.17 (+0.00%) | ||
| 0.3333:1 Stock Split | 2002-09-19 | 17,992.89 (-33.33%) | ||
| 0.1:1 Stock Split | 2002-02-15 | 78,722.45 (+0.00%) | ||
| 0.1:1 Stock Split | 2001-07-06 | 1,573,033.71 (-12.50%) |
Show
Entries
BioRegenx Inc Frequently Asked Questions
What is BioRegenx Inc(BRGX)'s stock price today?
The current price of BRGX is $0.01. The 52 week high of BRGX is $0.03 and 52 week low is $0.01.
When is next earnings date of BioRegenx Inc(BRGX)?
The next earnings date of BioRegenx Inc(BRGX) is .
Does BioRegenx Inc(BRGX) pay dividends? If so, how much?
BioRegenx Inc(BRGX) does not pay dividend.
Guru Commentaries on OTCPK:BRGX
No articles.
Press Release
Articles on BioRegenx Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers